|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01030978
|
3-hydroxybut-2-enoic acid
|
3-hydroxybut-2-enoic acid
|
FA 4:1;O
|
C4H6O3
|
102.031695
|
|
LMFA01030978
|
3-hydroxybut-2-enoic acid
|
3-hydroxybut-2-enoic acid
|
FA 4:1;O
|
C4H6O3
|
102.031695
|
|
LMFA01030981
|
3-Methylsubericacid
|
3-methylsuberic acid
|
FA 9:1;O2
|
C9H16O4
|
188.104860
|
|
LMFA01030981
|
3-Methylsubericacid
|
3-methylsuberic acid
|
FA 9:1;O2
|
C9H16O4
|
188.104860
|
|
LMFA01030982
|
4-ene-Valproic acid
|
2-propylpent-4-enoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA01030982
|
4-ene-Valproic acid
|
2-propylpent-4-enoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA01030983
|
4-Ethyloctanoic acid
|
4-ethyloctanoic acid
|
FA 10:0
|
C10H20O2
|
172.146330
|
|
LMFA01030983
|
4-Ethyloctanoic acid
|
4-ethyloctanoic acid
|
FA 10:0
|
C10H20O2
|
172.146330
|
|
LMFA01030984
|
4-Formyl-3-(formylmethyl)-4-hexenoic acid
|
(4E)-4-formyl-3-(2-oxoethyl)hex-4-enoic acid
|
FA 9:3;O2
|
C9H12O4
|
184.073560
|
|
LMFA01030985
|
4-Methyl-2-pentenoic acid
|
(2Z)-4-methylpent-2-enoic acid
|
FA 6:1
|
C6H10O2
|
114.068080
|
|
LMFA01030985
|
4-Methyl-2-pentenoic acid
|
(2Z)-4-methylpent-2-enoic acid
|
FA 6:1
|
C6H10O2
|
114.068080
|
|
LMFA01030987
|
5-Acetamidovalerate
|
5-acetamidopentanoic acid
|
|
C7H13NO3
|
159.089544
|
|
LMFA01030988
|
5-Decenoic acid
|
(5E)-dec-5-enoic acid
|
FA 10:1
|
C10H18O2
|
170.130680
|
|
LMFA01030989
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
FA 8:4;O4
|
C8H8O6
|
200.032090
|
|
LMFA01030989
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
FA 8:4;O4
|
C8H8O6
|
200.032090
|
|
LMFA01030994
|
8-Methylnonenoic acid
|
(6E)-8-methylnon-6-enoic acid
|
FA 10:1
|
C10H18O2
|
170.130680
|
|
LMFA01030994
|
8-Methylnonenoic acid
|
(6E)-8-methylnon-6-enoic acid
|
FA 10:1
|
C10H18O2
|
170.130680
|
|
LMFA01030999
|
but-1-ene-1,2,4-tricarboxylic acid
|
(1Z)-but-1-ene-1,2,4-tricarboxylic acid
|
FA 7:3;O4
|
C7H8O6
|
188.032090
|
|
LMFA01031001
|
C11354
|
(2E,4Z)-2-hydroxyhexa-2,4-dienoic acid
|
FA 6:2;O
|
C6H8O3
|
128.047345
|
|
LMFA01031001
|
C11354
|
(2E,4Z)-2-hydroxyhexa-2,4-dienoic acid
|
FA 6:2;O
|
C6H8O3
|
128.047345
|
|
LMFA01031004
|
cis-pent-2-enoic acid
|
(2Z)-pent-2-enoic acid
|
FA 5:1
|
C5H8O2
|
100.052430
|
|
LMFA01031005
|
cis-pent-3-enoic acid
|
(3Z)-pent-3-enoic acid
|
FA 5:1
|
C5H8O2
|
100.052430
|
|
LMFA01031011
|
hept-2-enedioic acid
|
hept-2-enedioic acid
|
FA 7:2;O2
|
C7H10O4
|
158.057910
|
|
LMFA01031012
|
hexa-2,4-dienoic acid
|
hexa-2,4-dienoic acid
|
FA 6:2
|
C6H8O2
|
112.052430
|
|
LMFA01031013
|
Lumequic acid
|
(21E)-triacont-21-enoic acid
|
FA 30:1
|
C30H58O2
|
450.443681
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031016
|
mediomycin B
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO15
|
1095.685825
|
|
LMFA01031018
|
penta-2,4-dienoic acid
|
penta-2,4-dienoic acid
|
FA 5:2
|
C5H6O2
|
98.036780
|
|
LMFA01031021
|
trans-2-hexacosenoic acid
|
(2E)-hexacos-2-enoic acid
|
FA 26:1
|
C26H50O2
|
394.381081
|
|
LMFA08020162
|
(E,E)-2,4-Decadienoic isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide
|
NA 14:2
|
C14H25NO
|
223.193614
|
|
LMFA08020162
|
(E,E)-2,4-Decadienoic isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide
|
NA 14:2
|
C14H25NO
|
223.193614
|
|
LMFA08020163
|
1-(4-carboxybutanamido)-1'-(dimethylcarbamoyl)ferrocene
|
{(1,2,3,4,5-eta)-1-(4-carboxybutanamido)cyclopentadienyl}[(1,2,3,4,5-eta)-1-(dimethylcarbamoyl)cyclopentadienyl]iron
|
|
C18H22N2O4Fe
|
386.092898
|
|
LMFA08020164
|
2,4-Undecadiene-8,10-diynoic acid isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA08020164
|
2,4-Undecadiene-8,10-diynoic acid isobutylamide
|
(2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA08020165
|
Anacyclin
|
(2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide
|
NA 18:6
|
C18H25NO
|
271.193614
|
|
LMFA08020165
|
Anacyclin
|
(2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide
|
NA 18:6
|
C18H25NO
|
271.193614
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020166
|
asukamycin
|
(2E,4E,6E)-7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]hepta-2,4,6-trienamide
|
|
C31H34N2O7
|
546.236603
|
|
LMFA08020167
|
beta-sanshool
|
(2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide
|
NA 16:4
|
C16H25NO
|
247.193614
|
|
LMFA08020167
|
beta-sanshool
|
(2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide
|
NA 16:4
|
C16H25NO
|
247.193614
|